Skip to content
Author

Peter Giordano

Peter Giordano, Founder & Editor of Grey Peptides

Founder & Editor

Grey Peptides · Independent health science research & education

LinkedIn →

About

Peter Giordano is the founder and editor of Grey Peptides, an independent peptide education resource built entirely on peer-reviewed literature, FDA regulatory filings, and clinical trial data. He created the site to fill a gap he saw in the peptide information landscape: most existing resources are either vendor-funded marketing or unsubstantiated community claims with no source attribution.

Grey Peptides operates with zero commercial bias — no peptide sales, no vendor commissions, and no compensated product reviews. Every claim is traceable to a published source, and evidence levels are graded honestly rather than inflated for engagement.

Editorial approach

Peter personally reviews every article and encyclopedia entry before publication. The editorial process follows a consistent methodology:

  • Primary sources first. FDA prescribing information, EMA product characteristics, PubMed-indexed peer-reviewed publications, ClinicalTrials.gov entries, and manufacturer regulatory filings form the foundation of every entry.
  • Honest evidence grading. Evidence levels (high / medium / low) reflect the actual strength of the underlying data — not marketing claims or community enthusiasm.
  • Clear regulatory labeling. FDA-approved compounds, investigational compounds, discontinued compounds, and research-only compounds are each labeled distinctly so readers know exactly where a substance stands.
  • Community dosing disclosed as community dosing. Where no regulator-endorsed dose exists, community protocols are reported and clearly labeled as non-clinical guidance.
  • Non-peptides flagged. Small molecules and full proteins that enter community discussion are included but identified as such.

The site

Grey Peptides currently includes a 296-entry peptide encyclopedia, 12 interactive research tools (including the Reconstitution Calculator, Protocol Builder, Half-Life Visualizer, and Drug Interaction Checker), and a growing library of long-form evidence-based guides. The site is designed as a reference work — the register of a medical encyclopedia rather than a blog or marketing site.

Corrections

Factual corrections are taken seriously. If an entry misstates a mechanism, misattributes a finding, or cites an outdated source, contact editors@greypeptides.com. Material corrections are made promptly and noted in the entry's metadata.